Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06839079 · ClinicalTrials.gov registry record · NA

Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment

A NA study of TBI (Traumatic Brain Injury) and Cognitive Symptoms, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06839079: Recruiting NA study of TBI (Traumatic Brain Injury) and Cognitive Symptoms, sponsored by Massachusetts General Hospital.

NCT06839079 is a NA study of TBI (Traumatic Brain Injury) and Cognitive Symptoms that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06839079, a NA study of TBI (Traumatic Brain Injury) and Cognitive Symptoms, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Researchers at Massachusetts General Hospital are looking to see if a program created to help improve thinking and memory can work for refugees with traumatic brain injury (TBI). They're checking if this program is practical and if people find it helpful. The study will have two groups. Participants will complete a first questionnaire and then be assigned to a group by chance. One group will participate in the program immediately and then answer the second questionnaire (approximately 3 months after the first questionnaire they did). Then they will wait and then answer the third and final questionnaire approximately 6 months after the first one. The second group will wait and answer the second questionnaire approximately 3 months after the first one. Then they will receive the program and answer the third and final questionnaire (approximately 6 months after the first one they did.)

Primary Outcome

At least 70% of participants will complete 7 or more sessions. At least 70% of participants will complete their homework. At least 80% of participants will complete the study and 12 weeks assessment. At least 60% of participants will complete the 24 weeks assessment.

Interventions

  • BEHAVIORAL A Trauma-informed, Paraprofessional Delivered Virtual Cognitive Rehabilitation Program

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10-15
Est. Completion 2027-12
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06839079 shows while recruiting

NCT06839079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 171-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (71% lower).

The record links to 2 conditions, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 1 intervention - of which A Trauma-informed, Paraprofessional Delivered Virtual Cognitive Rehabilitation Program is the first listed.

NCT06839079 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06839079 about?

NCT06839079 is a clinical study titled "Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment". Researchers at Massachusetts General Hospital are looking to see if a program created to help improve thinking and memory can work for refugees with traumatic brain injury (TBI). They're checking if this program is practical and if people find it helpful. The study will have two groups. Participant...

What is the current status of trial NCT06839079?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-15. Estimated completion is 2027-12.

What conditions does trial NCT06839079 study?

This clinical trial studies the following conditions: TBI (Traumatic Brain Injury), Cognitive Symptoms.

What interventions are being tested in trial NCT06839079?

The interventions under investigation include: A Trauma-informed, Paraprofessional Delivered Virtual Cognitive Rehabilitation Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06839079?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06839079 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for TBI (Traumatic Brain Injury)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06839079's enrollment target sits among peer trials

50 14th of 20 higher than 7 of 20 other TBI (Traumatic Brain Injury) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other TBI (Traumatic Brain Injury) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06839079, the US trial registry maintained by the National Library of Medicine. NCT06839079 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.